RSS

HIV

After receiving approval for two HIV drugs, Delstrigo and Pifeltro, Merck should be expecting strong sales but probably unlikely to be at blockbuster levels, according to senior pharma analyst at GlobalData. more

Analysis

As we approach World Health Day (7 April), which this year coincides with the 70th anniversary year of WHO and has a focus on ‘health for all’, we take a look at some key topics that have impacted pharma over the past six months… more

News

A recently published preliminary study involving primates has revealed that a form of engineered stem cell-derived chimeric antigen receptor (CAR) T-cells may be useful in the long-term suppression of HIV. more

News

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. more

News

In this online exclusive, Dr Neil Polwart, founder of Novarum DX and BBI group head of Mobile, explains why innovative diagnostic technology has a key role to play in HIV testing and prevention. more

News

Global pharmaceutical company, Mylan, is joining in the battle to prevent HIV infection by delivering the world’s biggest pre-exposure prophylaxis (PrEP) implementation trial, which will target an estimated 10,000 high risk people. more

News

Drug resistance in HIV is rising to more than 10% in people with HIV who are preparing to start (or re-start) first-line antiretroviral therapy, according to a recently published meta-analysis. more

News

PrEP drugs

Shutterstock.com

A three-year trial of the pre-exposure prophylaxis (PrEP) for the prevention of HIV infection has been announced by NHS England and will be the largest single study of its type in the world with an estimated 10,000 people expected to be included. more

News

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending marketing authorisation for a once-daily darunavir-based single tablet regimen (STR) for the treatment of HIV. more

News

MedMira — which develops rapid diagnostic technology platforms and testing solutions — has received the CE Mark for its syphilis/HIV rapid test, Multiplo TP/HIV. more

Technology

The FDA has not granted orphan drug designation (ODD) to CytoDyn for its PRO 140 therapy as it appears to have the potential to treat more than just the subset of multi-drug resistant HIV patients for which the designation was requested. more

News

Drug development company, Aelix Therapeutics, has appointed HIV expert, Dr Ian McGowan, as chief medical officer (CMO). more

News

Researchers at the University of North Carolina have been awarded a 3-year, $1.8 million grant by the NIH for the development of a new implantable drug delivery system for HIV/AIDS. more

News

With €134M ($140M) backing from the Bill & Melinda Gates Foundation, Intarcia Therapeutics is to develop its Medici drug delivery system that will reduce dosing frequency for HIV prevention medication. more

News

Kymab the Cambridge-based antibodies-to-medicines company, improves discovery and testing of promising HIV vaccine strategies through collaboration. more

News

NHS England has reiterated it cannot commission preventative HIV drug, PrEP (pre-exposure prophylaxis), explaining that the onus falls on local authorities more

News

HIV drug, nelfunavir, could stop one of the early changes in skin cancer cells that lead to them becoming resistant to treatment, according a study published in Cancer Cell more

News

Turing Pharmaceuticals posted a £9.7 million ($14.6m) net loss in the third quarter of 2015 and is now set to reduce the cost of Daraprim by 50% according to the company and The Wall Street Journal more

News

GlaxoSmithKline (GSK) has partnered with the Francis Crick Institute on an open science collaboration, the aim of which is to forge new scientific discoveries. more

News

Dr Raymond F Schinazi has been awarded the Distinguished Scientific Achievement Award by the American Liver Foundation. more

News